Market Insights Health Pharmacies OTC Products

Sleep Aids (Pharmacies) - United Kingdom

United Kingdom

Revenue in the Sleep Aids market is projected to reach €67.00m in 2024.
Revenue is expected to show an annual growth rate (CAGR 2024-2029) of 4.63%, resulting in a market volume of €84.00m by 2029.
In global comparison, most revenue will be generated in the United States (€1,366.00m in 2024).
In relation to total population figures, per person revenues of €0.99 are generated in 2024.

Key regions: United States, Germany, Australia, India, United Kingdom

Mercado

Región

Comparación de regiones

Moneda

Analyst Opinion

The Sleep Aids (Pharmacies) market in United Kingdom is experiencing steady growth, driven by changing customer preferences and underlying macroeconomic factors.

Customer preferences: Customers in the United Kingdom are increasingly seeking sleep aids to help them combat sleep disorders and improve the quality of their sleep. This shift in preferences can be attributed to factors such as high levels of stress, hectic lifestyles, and increasing awareness about the importance of sleep for overall well-being. As a result, there is a growing demand for sleep aids in the market.

Trends in the market: One of the key trends in the Sleep Aids (Pharmacies) market in United Kingdom is the rising popularity of natural and herbal sleep aids. Customers are becoming more conscious about the potential side effects of synthetic sleep aids and are opting for natural alternatives. This trend is driven by a growing interest in holistic wellness and a preference for organic and sustainable products. As a result, there has been an increase in the availability of natural sleep aids in pharmacies across the country. Another trend in the market is the growing popularity of over-the-counter sleep aids. Customers are increasingly turning to pharmacies for easily accessible and affordable sleep aids without the need for a prescription. This trend is driven by the convenience factor and the desire for self-care and self-medication. Pharmacies are responding to this trend by expanding their range of over-the-counter sleep aids and providing expert advice to customers.

Local special circumstances: The United Kingdom has a well-established pharmacy network, with a strong presence of both independent pharmacies and large pharmacy chains. This provides customers with easy access to sleep aids and expert advice from pharmacists. The National Health Service (NHS) also plays a significant role in the distribution of sleep aids, particularly for patients with sleep disorders. This combination of a robust pharmacy network and the support of the NHS contributes to the growth of the Sleep Aids (Pharmacies) market in United Kingdom.

Underlying macroeconomic factors: The Sleep Aids (Pharmacies) market in United Kingdom is influenced by several macroeconomic factors. One such factor is the aging population, as sleep disorders are more prevalent among older adults. As the population ages, the demand for sleep aids is expected to increase. Additionally, the increasing disposable income and changing lifestyles of the population contribute to the growth of the market. Customers are willing to spend more on sleep aids to improve their quality of life and overall well-being. In conclusion, the Sleep Aids (Pharmacies) market in United Kingdom is growing due to changing customer preferences, including a shift towards natural and over-the-counter sleep aids. The well-established pharmacy network and support from the NHS further contribute to the market's growth. The aging population and increasing disposable income are also underlying macroeconomic factors that drive the demand for sleep aids in the country.

Methodology

Data coverage:

The data encompasses B2C enterprises. Figures are based on offline and online spending by consumers, including VAT. Not included are B2B and B2G sales, or other pharmaceutical sales through hospitals or retail stores such as supermarkets.

Modeling approach:

Market sizes are determined through a bottom-up approach, building on specific predefined factors for each market market. As a basis for evaluating markets, we use industry associations, third-party studies and reports and survey results from our primary research (e.g., the Statista Global Consumer Survey). In addition, we use relevant key market indicators and data from country-specific associations, such as healthcare expenditure per country, consumer healthcare spending, GDP and internet penetration. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the relevant market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods. For forecasting digital trends such as the online-pharmacy sales share we use exponential trend smoothing and the s-curve method. The main drivers are healthcare expenditure per country and consumer healthcare spending.

Additional notes:

The data is modeled using current exchange rates. The impact of the COVID-19 pandemic and the Russia-Ukraine war are considered at a country-specific level. The market is updated twice a year. GCS data is reweighted for representativeness.